[go: up one dir, main page]

HRP20110563T1 - Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile - Google Patents

Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

Info

Publication number
HRP20110563T1
HRP20110563T1 HR20110563T HRP20110563T HRP20110563T1 HR P20110563 T1 HRP20110563 T1 HR P20110563T1 HR 20110563 T HR20110563 T HR 20110563T HR P20110563 T HRP20110563 T HR P20110563T HR P20110563 T1 HRP20110563 T1 HR P20110563T1
Authority
HR
Croatia
Prior art keywords
amino
cyanoethenyl
benzonitrile
dimethylphenyl
pyrimidinyl
Prior art date
Application number
HR20110563T
Other languages
Croatian (hr)
Inventor
Theodoor Paul
Peeters Jozef
Petrus Gerebern Vandecruys Roger
Elisabeth Stappers Alfred
Herman Copmans Alex
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2004/052028 external-priority patent/WO2005021001A1/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Priority claimed from EP05108086.9A external-priority patent/EP1632232B3/en
Publication of HRP20110563T1 publication Critical patent/HRP20110563T1/en
Publication of HRP20110563T4 publication Critical patent/HRP20110563T4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

Kruti farmaceutski sastav, naznačen time, da sadrži farmaceutski prihvatljiv nosač i kao aktivni sastojak terapeutski učinkovitu količinu spoja formule (I) njegov N-oksid ili njegov stereokemijski izomerni oblik. Patent sadrži još 43 patentna zahtjeva.A solid pharmaceutical composition comprising a pharmaceutically acceptable carrier and as the active ingredient a therapeutically effective amount of a compound of formula (I) its N-oxide or its stereochemically isomeric form. The patent contains another 43 patent claims.

HRP20110563TT 2004-09-03 2005-09-02 Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile HRP20110563T4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2004/052028 WO2005021001A1 (en) 2003-09-03 2004-09-03 Combinations of a pyrimidine containing nnrti with rt inhibitors
EP05101467 2005-02-25
EP05108086.9A EP1632232B3 (en) 2004-09-02 2005-09-02 Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile

Publications (2)

Publication Number Publication Date
HRP20110563T1 true HRP20110563T1 (en) 2011-09-30
HRP20110563T4 HRP20110563T4 (en) 2022-04-29

Family

ID=34938826

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20110563TT HRP20110563T4 (en) 2004-09-03 2005-09-02 Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

Country Status (2)

Country Link
HR (1) HRP20110563T4 (en)
NO (3) NO2017066I1 (en)

Also Published As

Publication number Publication date
NO2017066I1 (en) 2017-11-21
NO2017064I1 (en) 2017-11-21
NO2017062I1 (en) 2017-11-21
HRP20110563T4 (en) 2022-04-29

Similar Documents

Publication Publication Date Title
MEP33808A (en) PHARMACEUTICAL COMPOSITIONS CONCERNING HMG REDUCTASE INHIBITOR
LTPA2016042I1 (en) 4 [[4 - [[4- (2-Cyanoethenyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile salt
ES2421948T3 (en) Compounds and compositions for delivering active agents
WO2010030201A3 (en) Stable oral pharmaceutical composition containing a pharmaceutically acceptable salt of [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3r, 5s) - 3,5 dihydroxyhept-6- enoic acid
HRP20110563T1 (en) Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
NO20071720L (en) Fumarate of 4 - [[4 - [[4- (2-cyanoethenyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile.
UA92469C2 (en) Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile
UY28095A1 (en) PHARMACEUTICAL COMPOSITION
UY27049A1 (en) PHARMACEUTICAL COMPOSITIONS